Compound Summary
oxiracetam
Compound Information
oxiracetam
Compound Name: | oxiracetam |
Compound CID: | 4626 |
Synonyms: | oxiracetam 62613-82-5 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide 4-Hydroxy-2-oxopyrrolidine-N-acetamide ISF 2522 More... |
Iupac Name: | 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide |
InChI: | InChI=1S/C6H10N2O3/c7-5(10)3-8-2-4(9)1-6(8)11/h4,9H,1-3H2,(H2,7,10) |
InChIKey: | IHLAQQPQKRMGSS-UHFFFAOYSA-N |
Canonical Smiles: | C1C(CN(C1=O)CC(=O)N)O |
Isomeric Smiles: | C1C(CN(C1=O)CC(=O)N)O |
Molecular Weight: | 158.16 |
Molecular Formula: | C6H10N2O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
oxiracetam
Molecular Weight: | 158.16 |
Molecular Formula: | C6H10N2O3 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 11 |
Complexity: | 192 |
Synonyms
oxiracetam
| oxiracetam | oxiracetam |
|---|---|
oxiracetam |
62613-82-5 |
2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide |
4-Hydroxy-2-oxopyrrolidine-N-acetamide |
ISF 2522 |
1-Pyrrolidineacetamide, 4-hydroxy-2-oxo- |
4-Hydroxy-2-oxo-1-pyrrolidineacetamide |
(+-)-Oxiracetam |
CGP 21690E |
ISF-2522 |
CT-848 |
Oxiracetam(Random Configuration) |
UNII-P7U817352G |
CGP-21690E |
Hydroxypiracetam |
Neuromet |
GNF-PF-1005 |
(+-)-4-Hydroxy-2-oxo-1-pyrrolidineacetamide |
1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (+-)- |
MFCD00242951 |
P7U817352G |
NCGC00015768-02 |
Neuractiv |
(R)-(+)-Oxiracetam |
4-Hydroxypiracetam |
Oxiracetamum |
Oxiracetamum INN-Latin |
CCRIS 4221 |
Oxiracetam INN:BAN |
BRN 1529719 |
oxiractam |
Oriest |
Oxiracetam (INN) |
DSSTox_CID_25180 |
DSSTox_RID_80728 |
DSSTox_GSID_45180 |
Lopac0_000933 |
CHEMBL36633 |
SCHEMBL526050 |
DTXSID9045180 |
AMY5769 |
ISF2522 |
CHEBI:134788 |
HMS3262L08 |
HMS3652J06 |
HMS3885B17 |
ACT04730 |
BCP06209 |
BCP31146 |
HY-B1715 |
Tox21_110218 |
Tox21_500933 |
AC-670 |
CO0043 |
CS3412 |
s4270 |
AKOS013252523 |
AB05478 |
ACN-001375 |
CCG-205014 |
CS-8012 |
DB13601 |
LP00933 |
MCULE-8223030209 |
SDCCGSBI-0050907.P002 |
4- Hydroxy-2-oxopyrrolidine-N-acetamide |
4-hydroxypyrrolidin-2-on-1-yl acetamide |
NCGC00015768-03 |
NCGC00015768-04 |
NCGC00015768-07 |
NCGC00094242-01 |
NCGC00094242-02 |
NCGC00261618-01 |
4-hydroxy-2-oxopyrrolidin-1-yl-acetamide |
68567-97-5 |
AS-11801 |
AB0010774 |
CAS-62613-82-5 |
DB-054213 |
EU-0100933 |
FT-0630731 |
FT-0673341 |
FT-0673343 |
O0398 |
SW220157-1 |
2-(4-hydroxypyrrolidin-2-on-1-yl) acetamide |
EN300-75437 |
A21970 |
D07346 |
O 3011 |
613O825 |
A861378 |
Q415099 |
SR-01000076046 |
Q-201526 |
SR-01000076046-1 |
2-(4-HYDROXY-2-OXO-1-PYRROLIDINYL)ACETAMIDE |
R-Oxiracetam; (R)-ISF-2522;(R)-(+)-Oxiracetam |
Z1259086528 |
Experimental Data
oxiracetam
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 2.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
oxiracetam
Statistics Data
oxiracetam
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 2.000000000000000 | 1 | 1 |
Statistics Data Visualization
oxiracetam
